19/10/2022.
The iToBoS project has been presented in the journal ''Politici de Sanatate'' in the section ''Scoala Pacientilor'' on October 18, 2022.
17/10/2022.
This course supported by iToBoS project provides an overview on the concept of AI privacy, which helps in building trust in AI, and explains how open source tools from IBM can help both assess the privacy risk of AI-based solutions, and help them adhere to any relevant privacy requirements.
14/10/2022.
The iToBoS international project includes a novel total body scanner and a Computer Aided Diagnostics (CAD) tool, to integrate various data sources such as medical records, genomics data and imaging data. The first clinical study was created while iToBoS scanner is being manufactured.
11/10/2022.
In this blog we continue analyzing the importance of color accuracy in dermoscopy, considering multispectral dermoscopy, color constancy and consistency, greyscale and color resolution, and the use of smartphones in dermatology.
10/10/2022.
The assessment of dermoscopic images is based on the evaluation of color, shape and deep structures in the skin moles. Then image quality is of paramount importance for the diagnosis accuracy.
7/10/2022.
Some genes have been associated with the risk of melanoma. A mutation of in some high penetrance risk genes are associated with familial melanoma and multiple primary melanomas.
4/10/2022.
Privacy and Compliance for AI has been the topic of a few of our recent blog posts. It is a field that is well known and studied in the academic arena, but still relatively new in the industrial world.
3/10/2022.
The third issue of the iToBoS newsletter was released!
1/10/2022.
iToBoS project was presented in NTUA European Researchers’ Night in Athens on September 30, 2022.
1/10/2022.
iToBoS project is constantly active, not only in the development of the total body scanner and the Artificial Intelligence (AI) system, but also attending conferences, presenting the project in specialized congresses, conferences, or publishing scientific articles, among others.